Full-Time

Senior Director

Quality Assurance

Confirmed live in the last 24 hours

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

Biotechnology
Healthcare

Compensation Overview

$190k - $235kAnnually

+ Equity + Annual Bonus

Senior, Expert

Vancouver, BC, Canada

Category
QA & Testing
Quality Assurance
Requirements
  • You have a bachelor’s degree or equivalent and 15+ years experience within the biopharmaceutical or device industry
  • You have 12+ years experience in a quality organization in an FDA CBER/CDER and EMA regulated industry and you have previous experience within the areas of manufacturing or quality assurance
  • You have 6+ years of experience building, leading, developing, coaching and mentoring a cross-functional team
  • You have experience implementing phase-appropriate quality systems supporting CMC through IND/BLA in compliance with applicable regulations, guidelines and industry best practices
  • You have the ability to develop an overarching CMC/GMP QA strategy and inspire a team to deliver upon AbCellera’s vision and goals
  • You have a strong quality mindset and ability to influence across the entire organization
  • You are strongly self-motivated and are able to identify project needs and follow that up with building and implementing solutions
  • You are passionate about building dynamic new teams and capabilities that accomplish important goals
  • You have a bias towards innovation over industry standards
Responsibilities
  • Providing exceptional leadership to the organization, including hiring, mentoring and developing staff
  • Building the QA organization (CMC/GxP) and establishing, directing, coordinating and managing the reporting Quality Assurance (QA) functions
  • Developing and providing lifecycle management of the vendor/supplier selection, qualification and governance processes and internal/external audit programs
  • Designing, implementing and reviewing the Quality Management System (QMS) including deviations, change controls, CAPA, Annual Product Quality Review (APQRs), audit and inspection management programs, complaint management, recalls, etc.
  • Designing and implementing the document management system, quality risk management, knowledge management programs and systems
  • Designing and implementing quality governance, quality escalation and quality management review processes
  • Participating in the selection and governance/management of external vendors (e.g. CDMOs/CROs), leading quality due diligence activities and the negotiation, management and review of Technical Quality Agreements (QTAs), Knowledge Management/Data Integrity procedures/policies, etc.
  • Designing and management of equipment, facility, utility and related computer system validation programs. Ensuring implementation of facility/equipment/process control/monitoring/alarm programs where applicable
  • Collaborating with internal/external/partner cross-functional teams to ensure the timely and compliant progression of projects in accordance with approved project plans
  • Authoring and reviewing CMC INDs, BLAs, and other relevant regulatory dossier sections and strategizing to support responses to regulatory questions during review period and product lifecycle
  • Developing, implementing and monitoring phase-appropriate GxP and compliance systems, procedures and policies
  • Leading the Quality Assurance department program progression from lead candidate selection through pre-clinical, IND and/or commercial readiness (BLA) activities
  • Reviewing and approving match manufacturing and testing records and performing the QA release function
  • Ensuring activities and deliverables are in compliance with Health Canada, FDA, EMA and local regulations and guidance, ICH guidelines, AbCellera policies, SOPs and industry best practice

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Stage

Grant

Total Funding

$620.9M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

5%

1 year growth

0%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic collaborations with firms like Viking Global Investors and Biogen expand AbCellera's capabilities and market opportunities.
  • AbCellera's participation in high-profile industry conferences and presentations, such as AACR, showcases its cutting-edge research and strengthens its industry reputation.
  • The company's internal pipeline of therapeutic programs offers potential for significant breakthroughs and new treatments.

What critics are saying

  • The highly competitive and rapidly evolving biopharmaceutical market requires continuous innovation to maintain a competitive edge.
  • The recent resignation of board member Peter Thiel could lead to strategic and governance challenges.

What makes AbCellera Biologics unique

  • AbCellera's proprietary technology platform accelerates antibody discovery, making it faster and more efficient than traditional methods.
  • The company's ability to tackle challenging targets that have been difficult to address with traditional methods sets it apart in the biopharmaceutical market.
  • AbCellera's collaborative business model, which includes partnerships with leading investment firms and biotech companies, enhances its innovation and market reach.

Help us improve and share your feedback! Did you find this helpful?